A nationwide study of obstetric management and outcomes in premature rupture of membrane at term: Report from the Perinatology Committee, Japan Society of Obstetrics and Gynecology, 2017-2018.


Journal

The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761

Informations de publication

Date de publication:
Jan 2023
Historique:
revised: 14 09 2022
received: 22 08 2022
accepted: 19 09 2022
pubmed: 5 10 2022
medline: 19 1 2023
entrez: 4 10 2022
Statut: ppublish

Résumé

This nationwide study aimed to investigate the practical management of term premature rupture of membrane (PROM) and its relationship with maternal and neonatal outcomes. We conducted a questionnaire survey of 415 facilities participating in the Japan Perinatal Registry Network of the Japan Society of Obstetrics and Gynecology in 2016. The patients were women expecting vaginal birth after PROM at term without clinical chorioamnionitis. We classified the facilities into three groups based on duration of the expectant management after PROM (within 24, 24, and 48 h). Furthermore, we analyzed the association between perinatal outcomes and management protocol using the Japan Perinatal Registry Network Database 2016. Of 415 facilities, 346 (83.4%) completed and returned the survey. Among 231 facilities with management protocols, an interval of 3 days from PROM to delivery was acceptable in 167 facilities (72.3%). One hundred forty-nine facilities (64.5%) responded that they did not perform mechanical cervical dilation, and 90 (39.0%) used oxytocin as a uterotonic irrespective of cervical maturation. The number of hospitals that had a policy to administer antibiotics to Group B streptococcus-positive patients was 211 (91.3%). Neonatal outcomes at birth and the frequency of cesarean section and postpartum fever did not differ among the three groups. Most facilities in the Japan Perinatal Registry Network managed women at term to delivery within 3 days after PROM with attention to bacterial infection. Expectant management up to 48 h after PROM did not increase the risk of postpartum fever, compared to labor induction immediately after PROM.

Identifiants

pubmed: 36195467
doi: 10.1111/jog.15450
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-74

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 21K16811

Informations de copyright

© 2022 Japan Society of Obstetrics and Gynecology.

Références

Cammu H, Verlaenen H, Perde MP. Premature rupture of membranes at term in nulliparous women: a hazard? Obstet Gynecol. 1990;76(4):671-4.
Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta. 2006;27(11-12):1037-51.
Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med. 1996;334(16):1005-10.
Middleton P, Shepherd E, Flenady V, McBain RD, Crowther CA. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev. 2017;2017(1):CD005302.
Minakami H, Hiramatsu Y, Koresawa M, Fujii T, Hamada H, Iitsuka Y, et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition. J Obstet Gynaecol Res. 2011;37(9):1174-97.
Minakami H, Maeda T, Fujii T, Hamada H, Iitsuka Y, Itakura A, et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition. J Obstet Gynaecol Res. 2014;40(6):1469-99.
Itakura A, Satoh S, Akiba K, et al. CQ303: How should women with premature rupture of membranes (PROM) be treated? In: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists, editor. Guidelines for obstetrical practice in Japan: 2017 edition (in Japanese). Tokyo: Japan Society of Obstetrics and Gynecology; 2017. p. 158-62.
Itakura A, Satoh S, Aoki S, et al. CQ303: How should women with premature rupture of membranes (PROM) be treated? In: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists, editor. Guidelines for obstetrical practice in Japan: 2020 edition (in Japanese). Tokyo: Japan Society of Obstetrics and Gynecology; 2020. p. 142-6.
Itoh H, Ishii K, Shigeta N, Itakura A, Hamada H, Nagamatsu T, et al. Efficacy and safety of controlled-release dinoprostone vaginal delivery system (PROPESS) in Japanese pregnant women requiring cervical ripening: results from a multicenter, randomized, double-blind, placebo-controlled phase III study. J Obstet Gynaecol Res. 2021;47(1):216-25.
Kamiya K. Maternal and child health statistics of Japan. Tokyo: Mothers' & Children's Health & Welfare Association; 2017.
Itakura A, Satoh S, Aoki S, et al. CQ412-2: How should machanical dilators be used? In: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists, editor. Guidelines for obstetrical practice in Japan: 2020 edition (in Japanese). Tokyo: Japan Society of Obstetrics and Gynecology; 2020. p. 233-4.
Kurasawa K, Yamamoto M, Usami Y, Mochimaru A, Mochizuki A, Aoki S, et al. Significance of cervical ripening in pre-induction treatment for premature rupture of membranes at term. J Obstet Gynaecol Res. 2014;40(1):32-9.
Itakura A, Satoh S, Aoki S, et al. CQ603: How should women with genitourinary group B streptococcal (GBS) infection be treated? In: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists, editor. Guidelines for obstetrical practice in Japan: 2020 edition (in Japanese). Tokyo: Japan Society of Obstetrics and Gynecology; 2020. p. 297-9.

Auteurs

Tomoaki Oda (T)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Obstetrics & Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Nobuaki Mitsuda (N)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Maternal Fetal Medicine, Osaka Women's and Children's Hospital, Osaka, Japan.

Kei Miyakoshi (K)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Department of Obstetrics and Gynecology, International Catholic Hospital, Tokyo, Japan.

Shintaro Makino (S)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Department of Obstetrics and Gynecology, Juntendo University Urayasu Hospital, Urayasu, Japan.

Keisuke Ishii (K)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Maternal Fetal Medicine, Osaka Women's and Children's Hospital, Osaka, Japan.

Kentaro Kurasawa (K)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Takahiko Kubo (T)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Shirota Obstetrical and Gynecological Hospital, Zama, Japan.

Koichiro Shimoya (K)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Obstetrics and Gynecology, Kawasaki Medical School, Kurashiki, Japan.

Tomoaki Ikeda (T)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Tsu, Japan.

Naohiro Kanayama (N)

Perinatology Committee, Japan Society of Obstetrics and Gynecology, Tokyo, Japan.
Department of Obstetrics & Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Shizuoka College of Medicalcare Science, Hamamatsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH